Navigation Links
FDA approves first medical device using rutgers biomaterial

Rutgers scientists and TyRx Pharma, Inc., have announced the Food and Drug Administration's clearance of a new medical device for hernia repair that incorporates a biodegradable technology developed at the university. This action signals a paradigm shift in the application of biomaterials from permanent prosthetic replacements toward regenerative medicine, in which materials help the body to repair itself and are then resorbed.

The device consists of a surgical mesh coated with a polymer developed using a Rutgers bioresorbable technology. The polymer gives the surgical mesh improved handling characteristics that facilitate precise placement during the surgical repair and leave less implant material following the resorption of the coating.

Hernias occur when musculature fails and one part of the body protrudes through the resulting gap or opening into another part of the body. And although a hernia can theoretically develop almost anywhere, most are in the groin and abdominal areas.

The partially degradable device has been developed and will be marketed by TyRx Pharma, Inc., a medical device company founded in 1998.

"The company's early research was conducted at the Rutgers-based New Jersey Center for Biomaterials (CBM) in Rutgers' chemistry laboratories," said Joachim Kohn, CBM director and Board of Governors Professor of Chemistry and Chemical Biology at Rutgers, The State University of New Jersey. "This is an example of a close and strong academic-industry interaction that led to a relatively fast entrance of the product into the medical market."

Kohn pointed out that the technology was invented in 1997 and has progressed along a fast and efficient track to FDA approval ?a process that usually takes 10 years or more.

The invention was made with initial research support from the National Institutes of Health and demonstrates how a federal agency's funding can reap benefits for the American public. On a local level,
'"/>

Source:Rutgers, the State University of New Jersey


Page: 1 2

Related biology news :

1. Canada approves marijuana-based pain spray
2. FDA approves more generic AIDS drugs
3. FDA approves child-friendly AIDS medicine
4. Health Canada approves cold and flu medicine
5. A genes first kiss sets off that affair known as puberty
6. Love at first smell
7. Worlds largest rainforest drying experiment completes first phase
8. PCRM develops worlds first cruelty-free insulin assay
9. Expression Project for Oncology (expO) completes first phase of standardized gene expression analyses
10. World-first Living Donor Islet Cell Transplant A Success; Procedure Offers Promise For Diabetics
11. DuPonts first biologically derived polymer receives global recognition
Post Your Comments:
(Date:7/2/2008)..., , TALLAHASSEE, Fla. -- A Florida State Universi...s to evaluate a new class of cancer-killing drugs ...rchers. , Kevin C. Chen, an assistant professor ...ida A&M University-Florida State University Colleg...to determine how substances known as recombinant i...
(Date:7/2/2008)... Researchers at North Carolina State University ha...ate the skin if there is an abrasion, providing in...care workers or individuals involved in the manufa...tial biomedical applications of the tiny nanoparti... of different sizes, shapes and surface coatings d...
(Date:7/2/2008)... Grand Forks, North Dakota, July 2, 2008 Voluntee...ndation International (JDRF), the American Diabete... Board (NIHB) will present Senator Byron Dorgan wi... leadership on extending the Special Diabetes Prog...t 11:30 a.m. in the Buchli Room at the Hilton Gard...
(Date:7/2/2008)... This release is available in Spanish . , Mo...sult of interactions between proteins, which recog...calized on the protein surface. There are many kin...to study from the perspective of structural biolog...raction is brief and occurs through a large sectio...
Breaking Biology News(10 mins):FSU researcher using computers to hone cancer-fighting strategies 2Study shows quantum dots can penetrate skin through minor abrasions 2Sen. Byron Dorgan to be honored 2Scientists reveal the key mechanisms for affinity between transient binding proteins 2FEW Announces Legislative Goals for Remainder of 110th Congress 3B Delivers Fact Sheets to Legislators 15233 1FEW Announces Legislative Goals for Remainder of 110th Congress 3B Delivers Fact Sheets to Legislators 15233 2Bionovo to Present at the Cambria Capital Investor Meeting 15229 1Bionovo to Present at the Cambria Capital Investor Meeting 15229 2Bionovo to Present at the Cambria Capital Investor Meeting 15229 3Alexza Completes 2410 Million Equity Financing with Bio One Capital to Initiate Commercial Manufacturing in Singapore 4205 1Alexza Completes 2410 Million Equity Financing with Bio One Capital to Initiate Commercial Manufacturing in Singapore 4205 2Alexza Completes 2410 Million Equity Financing with Bio One Capital to Initiate Commercial Manufacturing in Singapore 4205 3Alexza Completes 2410 Million Equity Financing with Bio One Capital to Initiate Commercial Manufacturing in Singapore 4205 4Alexza Completes 2410 Million Equity Financing with Bio One Capital to Initiate Commercial Manufacturing in Singapore 4205 5Drugs Approved Under Deadline More Likely to Run Into Trouble Later 15224 1Drugs Approved Under Deadline More Likely to Run Into Trouble Later 15224 2Drugs Approved Under Deadline More Likely to Run Into Trouble Later 15224 3Drugs Approved Under Deadline More Likely to Run Into Trouble Later 15224 4
...th of daylight to which mice are exposed to can ch... The study found that in the short days of winter,...crease aggression in males of a particular type of...notus). , However, in the long days of summer, ...mice, a species commonly found in the southeastern...
...rom humanity,s birthplace in east Africa some 65,0...e DNA of each population, essentially providing a ...Recently some scientists have raised doubts about ...tions of people and to estimate the populations of...ds of years ago. , But University of Florida re...
... have identified the neurocircuit that controls th...it may be possible to understand psychiatric disor...rlying neurophysiology ?workings of the brain. , ... an attention control test, and a neuroimaging mac...n. , Published in the Sept. 21, 2006 issue of Ne...
...rs at the Translational Genomics Research Institut...rix 500K Array to discover a gene--called Kibra--a...eam,s findings may be used to develop new medicine...d Parkinson,s by providing scientists with a bette...ar level. , The study entitled, "Common KIBRA alle...
Other Biology News:Changing length of days reverses how estrogen affects aggressiveness in mice 2Changing length of days reverses how estrogen affects aggressiveness in mice 3Changing length of days reverses how estrogen affects aggressiveness in mice 4History-hunting geneticists can still follow familiar trail 2History-hunting geneticists can still follow familiar trail 3Emotional control circuit of brain's fear response discovered 2Emotional control circuit of brain's fear response discovered 3Affymetrix 500K array used to identify memory gene 2
(Date:7/2/2008)...immediately, SpectraCell,Laboratories now measures...its proprietary FIA(TM) (Functional Intracellular ...n to diagnose specific vitamin and mineral,deficie...ar. The demand for,testing Vitamin C levels in pat...ents an important addition to their existing panel...
(Date:7/2/2008)...inhua-PRNewswire-FirstCall/,-- China Pharma Holdin...PHI) which develops, manufactures, and markets gen...hina, today announced that the management will,pre...onference on Tuesday,July 8th at 2:00 p.m. EDT. T...al Hotel in New York City, NY., Mr. Xinhua Wu, Ch...
(Date:7/2/2008)...eting and Sales; Susan Koppy named as ...ND, Calif., July 2 /- Transcept Pharm...f Terrence Moore to the position of,Vice President...ion of Vice,President, Corporate Development. Both...& Chief Executive Officer Glenn A. Oclassen. "We a...
(Date:7/2/2008)...y Technology Receive Funding, From Allied Minds to... of Aliquots, BOST...d investment,corporation specializing in early sta...y,s Office of Technology Development, and Northeas...t Instruments, LLC, a new,spin-out focused on the ...
Breaking Biology Technology:SpectraCell Laboratories Now Measures Vitamin C 2China Pharma Holdings, Inc. to Present at Collins Stewart Fourth Annual Growth Conference in New York on July 8, 2008 at 2:00 p.m. EDT 2Transcept Pharmaceuticals Appoints Key Senior Executives 2Transcept Pharmaceuticals Appoints Key Senior Executives 3Transcept Pharmaceuticals Appoints Key Senior Executives 4Investment Firm Allied Minds to Commercialize New Frozen Aliquotter Technology with Two Local Major Universities. 2
..., Luis A Ugozzoli, Bio-Rad Laboratories, In...USA , , Introduction , ...refined since its advent 16 years ago. Several imp...ted equipment have significantly changed , ...er protocols. One of the , most remarkabl...
..., Kristina Lind and Mikael Kubista, TATAA B...Sweden , , Introduction , ...muno-PCR, was developed by , Sano et al. ...ntibodies , with the high DNA amplificati... to conventional enzyme-linked immunosorben...
..., Jessica N Ebright 1 and Catherine Bowes ...lmology and 2 Cell Biology, Duke University Medic... Correspondence: Catherine Bowes Rickman, PhD, D...sity Medical Center, Box 3802, Durham, NC 27710, P..., E-mail: bowes007@duke.edu , , ...
..., , , Difference gel electrop... application of differential labeling of pr...he technique, originally published by Unlu et al. ...rentially label proteins separated by 2-D gel , ...ctrophoresis, excellent results , can be ...
Other Biology Technology:The Gradient Feature: Use in Optimization of Allelic Discrimination Assays, Rev B 2The Gradient Feature: Use in Optimization of Allelic Discrimination Assays, Rev B 3The Gradient Feature: Use in Optimization of Allelic Discrimination Assays, Rev B 4The Gradient Feature: Use in Optimization of Allelic Discrimination Assays, Rev B 5The Gradient Feature: Use in Optimization of Allelic Discrimination Assays, Rev B 6The Gradient Feature: Use in Optimization of Allelic Discrimination Assays, Rev B 7The Gradient Feature: Use in Optimization of Allelic Discrimination Assays, Rev B 8Real-Time Immuno-PCR on the iCycler iQ System, Rev A 2Real-Time Immuno-PCR on the iCycler iQ System, Rev A 3Real-Time Immuno-PCR on the iCycler iQ System, Rev A 4Real-Time Immuno-PCR on the iCycler iQ System, Rev A 5Rapid, Reproducible Real-Time Quantitative RT-PCR Using the iCycler iQ Real-Time PCR Detection System and iQ Supermix, Rev A 2Rapid, Reproducible Real-Time Quantitative RT-PCR Using the iCycler iQ Real-Time PCR Detection System and iQ Supermix, Rev A 3Rapid, Reproducible Real-Time Quantitative RT-PCR Using the iCycler iQ Real-Time PCR Detection System and iQ Supermix, Rev A 4Rapid, Reproducible Real-Time Quantitative RT-PCR Using the iCycler iQ Real-Time PCR Detection System and iQ Supermix, Rev A 5Rapid, Reproducible Real-Time Quantitative RT-PCR Using the iCycler iQ Real-Time PCR Detection System and iQ Supermix, Rev A 6Rapid, Reproducible Real-Time Quantitative RT-PCR Using the iCycler iQ Real-Time PCR Detection System and iQ Supermix, Rev A 7Rapid, Reproducible Real-Time Quantitative RT-PCR Using the iCycler iQ Real-Time PCR Detection System and iQ Supermix, Rev A 8Imaging and Analysis of DIGE Product Information Sheet, Rev B 2Imaging and Analysis of DIGE Product Information Sheet, Rev B 3Imaging and Analysis of DIGE Product Information Sheet, Rev B 4Imaging and Analysis of DIGE Product Information Sheet, Rev B 5Imaging and Analysis of DIGE Product Information Sheet, Rev B 6Imaging and Analysis of DIGE Product Information Sheet, Rev B 7
GC-RICH PCR System from Roche Applied Science
BD Falcon Center-well 60 mm In Vitro Fertilization (IVF) Dish, nonembryotoxic, noncytotoxic, tissue-culture treated polystyrene. (20/sp, 500/ca) Packaging: 20 / sleeve, 500 / case
BssH II Bacillus stearothermophilus from Sigma-Aldrich
BD BioCoat Poly-D-Lysine/Laminin 100 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of poly-D-lysine and laminin.
Biology Products: